Dentsply Sirona/$XRAY

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Dentsply Sirona

Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (manufactured dental consumables and lab products) and Sirona Dental Systems (manufactured technologically-advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology and equipment through third-party distributors and the remaining portfolio is either sold to labs and offices through the firm's salesforce or directly to consumers (such as Byte clear aligner).

Ticker

$XRAY
Primary listing

Industry

Health Care Equipment and Supplies

Employees

14,000

ISIN

US24906P1093

Dentsply Sirona Metrics

BasicAdvanced
$3.1B
-
-$4.52
0.96
$0.64
4.06%

What the Analysts think about Dentsply Sirona

Analyst ratings (Buy, Hold, Sell) for Dentsply Sirona stock.

Bulls say / Bears say

Dentsply Sirona's Q1 2025 adjusted earnings per share of $0.43 exceeded analyst expectations of $0.30, indicating strong operational performance. (Benzinga)
The company raised its full-year 2025 revenue guidance to a range of $3.60 billion–$3.70 billion, reflecting confidence in sustained growth. (Benzinga)
Dentsply Sirona's strategic review of its Wellspect Healthcare business could unlock significant value, allowing the company to focus more on its core dental business. (StockTitan)
In Q2 2024, Dentsply Sirona reported adjusted earnings per share of $0.49, missing the consensus estimate of $0.50, and experienced a 4.2% year-over-year revenue decline. (Nasdaq)
The company revised its 2024 revenue guidance downward to $3.86–$3.90 billion from the previous range of $3.91–$3.97 billion, indicating potential challenges in meeting earlier growth expectations. (Nasdaq)
Analysts have downgraded Dentsply Sirona's stock, with Wells Fargo lowering its price target from $20.00 to $19.00 and maintaining an 'equal weight' rating, reflecting cautious sentiment. (Defense World)
Data summarised monthly by Lightyear AI. Last updated on 12 Jul 2025.

Dentsply Sirona Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Dentsply Sirona Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $XRAY

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events
FAQs